SAFIA Technologies GmbH is a spin-off of the Federal Institute for Materials Research and Testing (BAM). The founding project specializes in the development of antibody-based analysis kits (immunoassays) based on SAFIA technology. As a platform technology, SAFIA technology is suitable for use in ...

more

SAFIA Technologies GmbH is a spin-off of the Federal Institute for Materials Research and Testing (BAM). The founding project specializes in the development of antibody-based analysis kits (immunoassays) based on SAFIA technology. As a platform technology, SAFIA technology is suitable for use in ...

more

LIMAA Technologies GmbH is a deep-tech spinoff from Charité University Hospital, providing advanced medical technology solutions, specializing on the development and commercialization of reagents, hardware and software for their end-to-end fully automated histology platform enhancing diagnostic ...

more

We develop reversion therapeutic technologies to revert cancer and aging.

more

Instrumentation and services for the characterization of chiral molecules. Let ENANTIOS measure for you with our Proof–of-concept or Molecule Measurement services. Send us your molecule and we send you back all the structural information you need.

more

Instrumentation and services for the characterization of chiral molecules. Let ENANTIOS measure for you with our Proof–of-concept or Molecule Measurement services. Send us your molecule and we send you back all the structural information you need.

more

Developed a metabolome based a diagnostic gut function test (GFT). GFT goes beyond diagnosis to help designing personalized probiotic formulation for prophylaxis and intervention.

more

Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative ...

more

Myria Biosciences is at the forefront of applying synthetic intelligence to transform drug development. The company's GEMMS (Genetically Engineered Modular Molecule Scaffolds) platform combines synthetic biology and artificial intelligence into a synthetic intelligence approach that allows the ...

more

Revolutionizing in-vitro studies with mechanically-stimulated, human-like organ-on-chip models, for the development of pharmaceuticals and treatments for arthritis and related diseases.

more